Form 4 Tracker
UNITED THERAPEUTICS Corp
UTHR

260 insider filings · Latest: Oct 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Nov 4, 2024Nov 4 9:06 PMJAMES EDGEMOND
Proposed Sale
7,778$374.02$2.9M—

View →

Nov 1, 2024Nov 1 8:45 PMCHRISTOPHER CAUSEY
Proposed Sale
510$376.63$192.1K—

View →

Nov 1, 2024Nov 1 8:23 PMMICHAEL I BENKOWITZ REVOCABLE TRUST
Proposed Sale
14,700$374.46$5.5M—

View →

Oct 28, 2024Oct 28 8:13 PMJAMES EDGEMOND
Proposed Sale
7,800$350.00$2.7M—

View →

Oct 21, 2024Oct 21 8:07 PMJAMES EDGEMOND
Proposed Sale
7,782$366.99$2.9M—

View →

Oct 14, 2024Oct 15 12:19 PMJAMES EDGEMOND
Proposed Sale
7,792$355.88$2.8M—

View →

Oct 7, 2024Oct 7 8:09 PMJAMES EDGEMOND
Proposed Sale
7,794$355.54$2.8M—

View →

Sep 30, 2024Sep 30 8:04 PMJAMES EDGEMOND
Proposed Sale
7,792$358.62$2.8M—

View →

Sep 23, 2024Sep 23 8:02 PMJAMES EDGEMOND
Proposed Sale
7,796$354.04$2.8M—

View →

Sep 17, 2024Sep 17 8:04 PMJUDY OLIAN
Proposed Sale
2,300$353.22$812.4K—

View →

Sep 16, 2024Sep 16 8:20 PMJAMES EDGEMOND
Proposed Sale
7,810$339.12$2.6M—

View →

Sep 9, 2024Sep 9 8:14 PMJAMES EDGEMOND
Proposed Sale
7,802$345.41$2.7M—

View →

Sep 4, 2024Sep 4 8:14 PMCHRISTOPHER PATUSKY
Proposed Sale
4,300$353.36$1.5M—

View →

Sep 3, 2024Sep 3 8:35 PMCHRISTOPHER PATUSKY
Proposed Sale
700$360.31$252.2K—

View →

Sep 3, 2024Sep 3 8:18 PMJAMES EDGEMOND
Proposed Sale
7,785$362.37$2.8M—

View →

Aug 26, 2024Aug 26 8:24 PMJAMES EDGEMOND
Proposed Sale
7,799$347.60$2.7M—

View →

Aug 21, 2024Aug 21 8:05 PMCHRISTOPHER CAUSEY
Proposed Sale
1,210$349.00$422.3K—

View →

Nov 11, 2024—JUDY OLIAN
Proposed Sale
1,750$412.48$721.8K—

View →

Nov 6, 2024—Michael Benkowitz
Proposed Sale
40,000$382.77$15.3M—

View →

← Previous

Page 22 of 22

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 15, 2026Mar 17 9:10 PMJames EdgemondCFO AND TREASURER
Option Exercise
19,478—0(D)

View →

Mar 15, 2026Mar 17 9:09 PMPaul A MahonEVP & GENERAL COUNSEL
Option Exercise
16,691—0(D)

View →

Mar 15, 2026Mar 17 9:09 PMMartine A RothblattDirector, Chairperson & CEO
Option Exercise
69,579—0(D)

View →

Mar 13, 2026Mar 16 8:30 PMMartine A RothblattDirector, Chairperson & CEO
Option Exercise
9,500$146.03145,000(D)

View →

Mar 12, 2026Mar 16 12:30 PMMartine A RothblattDirector, Chairperson & CEO
Option Exercise
9,500$146.03154,500(D)

View →

Mar 11, 2026Mar 11 11:31 PMMartine A RothblattDirector, Chairperson & CEO
Option Exercise
9,500$146.03164,000(D)

View →

Mar 10, 2026Mar 11 8:30 PMMartine A RothblattDirector, Chairperson & CEO
Option Exercise
9,500$146.03173,500(D)

View →

Mar 9, 2026Mar 10 8:34 PMMartine A RothblattDirector, Chairperson & CEO
Option Exercise
9,500$146.03183,000(D)

View →

Mar 6, 2026Mar 10 8:33 PMMartine A RothblattDirector, Chairperson & CEO
Option Exercise
9,500$146.03192,500(D)

View →

Mar 5, 2026Mar 9 8:36 PMMartine A RothblattDirector, Chairperson & CEO
Option Exercise
9,500$146.03202,000(D)

View →

Mar 5, 2026Mar 5 9:37 PMPaul A MahonEVP & GENERAL COUNSEL
Option Exercise
8,300$146.0333,500(D)

View →

Mar 4, 2026Mar 5 9:36 PMMartine A RothblattDirector, Chairperson & CEO
Option Exercise
9,500$146.03211,500(D)

View →

Mar 4, 2026Mar 5 9:36 PMRay KurzweilDirector
Option Exercise
4,910$101.800(D)

View →

Mar 4, 2026Mar 5 9:35 PMTommy G ThompsonDirector
Option Exercise
2,000$101.802,000(D)

View →

Mar 4, 2026Mar 5 9:34 PMChristopher CauseyDirector
Option Exercise
20$119.766,300(D)

View →

Mar 3, 2026Mar 5 9:33 PMMartine A RothblattDirector, Chairperson & CEO
Option Exercise
9,500$146.03221,000(D)

View →

Mar 2, 2026Mar 3 9:31 PMMartine A RothblattDirector, Chairperson & CEO
Option Exercise
9,500$146.03230,500(D)

View →

Mar 15, 2023Feb 26 9:31 PMPaul A MahonEVP & GENERAL COUNSEL
Grant/Award
66,551$217.508,895(D)

View →

Mar 15, 2023Feb 26 9:31 PMMartine A RothblattDirector, Chairperson & CEO
Grant/Award
277,299$217.5037,080(D)

View →

Mar 15, 2023Feb 26 9:30 PMMichael BenkowitzPRESIDENT AND COO
Grant/Award
133,102$217.5017,790(D)

View →